Microneedle patches for vaccine delivery
- PMID: 24427762
- PMCID: PMC3890449
- DOI: 10.7774/cevr.2014.3.1.42
Microneedle patches for vaccine delivery
Abstract
In today's medical industry, the range of vaccines that exist for administration in humans represents an eclectic variety of forms and immunologic mechanisms. Namely, these are the live attenuated viruses, inactivated viruses, subunit proteins, and virus-like particles for treating virus-caused diseases, as well as the bacterial-based polysaccharide, protein, and conjugated vaccines. Currently, a new approach to vaccination is being investigated with the concept of DNA vaccines. As an alternative delivery route to enhance the vaccination efficacy, microneedles have been devised to target the rich network of immunologic antigen-presenting cells in the dermis and epidermis layers under the skin. Numerous studies have outlined the parameters of microneedle delivery of a wide range of vaccines, revealing comparable or higher immunogenicity to conventional intramuscular routes, overall level of stability, and dose-sparing advantages. Furthermore, recent mechanism studies have begun to successfully elucidate the biological mechanisms behind microneedle vaccination. This paper describes the current status of microneedle vaccine research.
Keywords: Bacterial vaccines; DNA vaccines; Microneedles; Transdermal delivery; Virus vaccines.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Microneedles: A New Generation Vaccine Delivery System.Micromachines (Basel). 2021 Apr 14;12(4):435. doi: 10.3390/mi12040435. Micromachines (Basel). 2021. PMID: 33919925 Free PMC article. Review.
-
Microneedle Patches as Drug and Vaccine Delivery Platform.Curr Med Chem. 2017;24(22):2413-2422. doi: 10.2174/0929867324666170526124053. Curr Med Chem. 2017. PMID: 28552053 Review.
-
Microneedles for vaccine delivery: challenges and future perspectives.Ther Deliv. 2017 Jun;8(6):447-460. doi: 10.4155/tde-2017-0032. Ther Deliv. 2017. PMID: 28530151 Review.
-
Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity.Clin Vaccine Immunol. 2011 Apr;18(4):647-54. doi: 10.1128/CVI.00435-10. Epub 2011 Feb 2. Clin Vaccine Immunol. 2011. PMID: 21288996 Free PMC article.
-
Microneedle-based vaccines.Curr Top Microbiol Immunol. 2009;333:369-93. doi: 10.1007/978-3-540-92165-3_18. Curr Top Microbiol Immunol. 2009. PMID: 19768415 Free PMC article. Review.
Cited by
-
Current Status of Microneedle Array Technology for Therapeutic Delivery: From Bench to Clinic.Mol Biotechnol. 2023 Nov 21. doi: 10.1007/s12033-023-00961-2. Online ahead of print. Mol Biotechnol. 2023. PMID: 37987985 Review.
-
Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo.Vaccines (Basel). 2023 Mar 31;11(4):780. doi: 10.3390/vaccines11040780. Vaccines (Basel). 2023. PMID: 37112692 Free PMC article.
-
A Review of 3D-Printing of Microneedles.Pharmaceutics. 2022 Dec 1;14(12):2693. doi: 10.3390/pharmaceutics14122693. Pharmaceutics. 2022. PMID: 36559187 Free PMC article. Review.
-
A microarray patch SARS-CoV-2 vaccine induces sustained antibody responses and polyfunctional cellular immunity.iScience. 2022 Oct 21;25(10):105045. doi: 10.1016/j.isci.2022.105045. Epub 2022 Aug 30. iScience. 2022. PMID: 36062075 Free PMC article.
-
Low-Temperature Multiple Micro-Dispensing on Microneedles for Accurate Transcutaneous Smallpox Vaccination.Vaccines (Basel). 2022 Apr 4;10(4):561. doi: 10.3390/vaccines10040561. Vaccines (Basel). 2022. PMID: 35455310 Free PMC article.
References
-
- Schwartz M. The life and works of Louis Pasteur. J Appl Microbiol. 2001;91:597–601. - PubMed
-
- Girard MP, Osmanov SK, Kieny MP. A review of vaccine research and development: the human immunodeficiency virus (HIV) Vaccine. 2006;24:4062–4081. - PubMed
-
- Dean CH, Alarcon JB, Waterston AM, et al. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccin. 2005;1:106–111. - PubMed
-
- Hirschberg HJ, van de Wijdeven GG, Kraan H, Amorij JP, Kersten GF. Bioneedles as alternative delivery system for hepatitis B vaccine. J Control Release. 2010;147:211–217. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials